U-Blot® Research Grade LandogrozumabCat. No. WA3040$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade LandogrozumabCat. No. WA3040
U-Blot® Research Grade LancastotugCat. No. WA3039
U-Blot® Research Grade LanadelumabCat. No. WA3038
U-Blot® Research Grade LampalizumabCat. No. WA3037
U-Blot® Research Grade LafuvitugCat. No. WA3036
U-Blot® Research Grade LadiratuzumabCat. No. WA3035
U-Blot® Research Grade ladarutatugCat. No. WA3034
U-Blot® Research Grade LacutamabCat. No. WA3033
U-Blot® Research Grade LacnotuzumabCat. No. WA3032
U-Blot® Research Grade LabetuzumabCat. No. WA3031
U-Blot® Research Grade KeliximabCat. No. WA3030
U-Blot® Research Grade JTX-8064-101Cat. No. WA3029